One major rookie mistake when making the rounds for a Series A: Approaching the most active investors before you’ve had time to practice. A panel of medtech CEOs and venture capitalists spoke on the challenges in raising a Series A round at this week’s MedTech Investment Conference. Here’s what they had to say:
1. Hang back before you approach the most active investors
There are multiple active investors in the medtech space, with firms like New Enterprise Associates, BioStar and Emergent Venures leading the pack. However, it’s not prudent to approach these firms at too early a stage.
Hey, check out all the engineering jobs. Post your resume today!
